Name
OÜ Perearst Boriss Slepikovski
Registry code
11560179
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.12.2008 (15)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
310 473 €
581 €
0%
2 610 €
(estimate is approximate)
87 378 €
3
Submitted
No tax arrears
1%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Boriss Slepikovski 07.09.1948 (76) | 100% - 2 556.00 EUR | Board member | - | Founder |
| 2019 02.06.2020 | 2020 01.03.2021 | 2021 15.03.2022 | 2022 14.03.2023 | 2023 01.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 186 224 € | 200 905 € | 228 984 € | 247 909 € | 310 473 € |
| Net profit (loss) for the period | 15 963 € | 18 831 € | 36 804 € | 20 235 € | 581 € |
| Profit Margin | 9% | 9% | 16% | 8% | 0% |
| Current Assets | 23 156 € | 29 421 € | 24 721 € | 53 582 € | 62 697 € |
| Fixed Assets | 13 239 € | 11 806 € | 52 640 € | 55 730 € | 54 182 € |
| Total Assets | 36 395 € | 41 227 € | 77 361 € | 109 312 € | 116 879 € |
| Current Liabilities | 15 468 € | 11 469 € | 10 799 € | 22 515 € | 29 501 € |
| Non Current Liabilities | 0 € | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 20 927 € | 29 758 € | 66 562 € | 86 797 € | 87 378 € |
| Employees | 3 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 17 534.76 € | 18 305.67 € | 3 |
| 2023 Q4 | - | 12 155.26 € | 12 617.67 € | 3 |
| 2023 Q3 | - | 10 956.87 € | 11 357.28 € | 3 |
| 2023 Q2 | - | 9 841.93 € | 10 170.42 € | 3 |
| 2023 Q1 | - | 10 799.66 € | 10 950.2 € | 3 |
| 2022 Q4 | - | 10 546.14 € | 10 765.32 € | 3 |
| 2022 Q3 | - | 9 690.63 € | 9 827.73 € | 3 |
| 2022 Q2 | - | 10 256.27 € | 10 418.1 € | 3 |
| 2022 Q1 | - | 8 640.28 € | 8 688.98 € | 3 |
| 2021 Q4 | - | 10 319.57 € | 10 447.6 € | 3 |
| 2021 Q3 | - | 9 235.74 € | 9 399.72 € | 3 |
| 2021 Q2 | - | 8 773.45 € | 8 937.24 € | 3 |
| 2021 Q1 | - | 8 356.94 € | 8 446.95 € | 3 |
| 2020 Q4 | - | 12 300.86 € | 10 012.41 € | 3 |
| 2020 Q3 | - | 9 123.62 € | 9 275.08 € | 3 |
| 2020 Q2 | - | 8 725.46 € | 8 860.64 € | 3 |
| 2020 Q1 | - | 8 751.09 € | 8 835.14 € | 3 |
